Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth (Q81242198)
Jump to navigation
Jump to search
scientific article published on 01 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth |
scientific article published on 01 January 2007 |
Statements
Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth (English)
Thomas Lam
John W Hetherington
John Greenman
Samantha Little
Anthony Maraveyas